GGrantIndex
Sort

53,477 grants matching addiction

Metabolic impact on T cell-mediated cancer immunity and therapy

$646,476
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Metabolic impact on T cell-mediated cancer immunity and therapy

$646,425
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure

$646,355
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2019 · ES

Genetic Dissection of Glutamate Receptor Function

$646,224
Salk Institute For Biological Studies · R01 · FY2004 · NS

Discovery of Bifunctional NOP/Opioid Receptor Ligands for Drug Abuse Therapy

$646,183
Nurulain T Zaveri · Astraea Therapeutics, Llc · R01 · FY2011 · DA

Plasticity of Aversive Salience in Opioid Use Disorder

$646,149
Jennifer Lorraine Stewart · Laureate Institute For Brain Research · R01 · FY2022 · DA

Behavior-based discovery of small-molecule modulators of neurochemical signaling pathways that underlie addiction

$646,068
Niels Ringstad · New York University School Of Medicine · R01 · FY2022 · DA

Development of Novel Opioid Peptides for Cocaine Abuse

$646,056
Jane V Aldrich · University Of Kansas Lawrence · R01 · FY2013 · DA

Smoking Cessation Interventions and Program Availability for Drug and Alcohol Add

$646,046
Jessica Legge Muilenburg · University Of Georgia · R01 · FY2011 · DA

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder

$646,039
Elisha Wachman · Boston Medical Center · R01 · FY2020 · HD

Microdialysis Studies of Self-administrationx

$645,968
Roy A Wise · National Institute On Drug Abuse · ZIA · FY2016 · DA

Biological Risk Factors in Relatives of Alcoholic Women

$645,957
Shirley Y. Hill · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AA

An adoption study of the development of early substance use: the joint roles of genetic influences, prenatal risk, rearing environment, and pubertal maturation

$645,889
Jenae M. Neiderhiser · Pennsylvania State University, The · R01 · FY2019 · DA

Adaptive Interventions to Improve Alcohol Treatment Engagement among Alcohol-related Liver Disease Patients

$645,878
Jessica Leigh Mellinger · University Of Michigan At Ann Arbor · R01 · FY2024 · AA

Nociceptin/Orphanin FQ, NOPR and Sleep/Wake

$645,873
Thomas S Kilduff · Sri International · R21 · FY2020 · NS

Therapeutic targeting of SIRT3 for aggressive and refractory lymphomas

$645,866
Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symporters

$645,811
Jonathan A Javitch · Columbia University Health Sciences · R01 · FY2011 · DA

NON-DEPENDENT OPIOID MISUSERS AS GWAS CONTROLS

$645,723
Elliot C Nelson · Washington University · R01 · FY2020 · DA

Structural Basis of Signal Instigation Through Family C GPCRs

$645,521
Georgios Skiniotis · Stanford University · R01 · FY2021 · NS

Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction

$645,337
Renato Polimanti · Yale University · R33 · FY2023 · DA

A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans

$645,205
Kelly E Dunn · Johns Hopkins University · R01 · FY2015 · DA

NorthStar Node of the NIDA Clinical Trials Network

$645,202
Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2025 · DA

Organizational Change and Nicotine Dependence Treatment

$645,125
Joseph R Guydish · University Of California, San Francisco · R01 · FY2008 · DA

A DUAL CHIMERIC HUMAN ASTROGLIAL-MICROGLIAL MODEL OF HIV AND HAND

$645,089
Steven A Goldman · University Of Rochester · R01 · FY2023 · DA

Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment

$644,996
Michael Scott Gordon · Friends Research Institute, Inc. · R01 · FY2016 · DA